SCHEMBL7109596

SCHEMBL7109596

Cc1ccc2nc(-c3ccc(N)c(Br)c3)sc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 9/20 0.68
MAPT P10636 7/20 0.68
RAB9A P51151 4/20 0.68
KDM4E B2RXH2 4/20 0.68
NPC1 O15118 3/20 0.68
GLA P06280 3/20 0.68
GAA P10253 3/20 0.68
SNCA P37840 1/20 0.57
CCNE1 P24864 1/20 0.53
CDK2 P24941 1/20 0.53
CDK5 Q00535 1/20 0.53
CDK5R1 Q15078 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
TP53 P04637 2/20 0.52
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
CASP3 P42574 1/20 0.49
KMT2A Q03164 1/20 0.49
SENP8 Q96LD8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8532762 0.86 MAPT (0.67) APPMAPTRAB9AKDM4ENPC1
SCHEMBL10311766 0.83 APP (0.68) APPMAPTRAB9AKDM4ENPC1
SCHEMBL7104765 0.83 APP (0.71) APPMAPTRAB9AKDM4ENPC1
SCHEMBL5691307 0.83 APP (0.68) APPMAPTRAB9AKDM4ENPC1
SCHEMBL4848589 0.81 MAPT (0.76) APPMAPTRAB9AKDM4ENPC1
SCHEMBL1978135 0.81 APP (0.69) APPMAPTRAB9AKDM4ENPC1
SCHEMBL2628249 0.81 APP (0.94) APPMAPTRAB9AKDM4ENPC1
SCHEMBL12422175 0.81 APP (0.64) APPMAPTRAB9AKDM4ENPC1
SCHEMBL492713 0.81 APP (1.00) APPMAPTRAB9AKDM4ENPC1
SCHEMBL2950103 0.81 APP (0.72) APPMAPTRAB9AKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812319-B9 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2003-10-08 EP claimed
EP-0812319-B1 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2002-07-10 EP claimed
US-6034246-A ANTICANCER AGENT CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-03-07 US claimed
WO-1996026932-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-09-06 WO claimed
EP-0812319-B9 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2003-10-08 EP disclosed
EP-0812319-B1 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2002-07-10 EP disclosed
US-6034246-A ANTICANCER AGENT CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-03-07 US disclosed
EP-0812319-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1997-12-17 EP disclosed
WO-1996026932-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-09-06 WO disclosed